Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to -$27.4 million.

  • Anaptysbio's Cash from Operations fell 17111.99% to -$27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$145.0 million, marking a year-over-year decrease of 4073.04%. This contributed to the annual value of -$135.3 million for FY2024, which is 1203.39% down from last year.
  • Anaptysbio's Cash from Operations amounted to -$27.4 million in Q3 2025, which was down 17111.99% from -$40.2 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Cash from Operations ranged from a high of $9.6 million in Q2 2021 and a low of -$66.7 million during Q4 2024
  • For the 5-year period, Anaptysbio's Cash from Operations averaged around -$23.9 million, with its median value being -$24.1 million (2022).
  • Per our database at Business Quant, Anaptysbio's Cash from Operations surged by 14890.87% in 2021 and then plummeted by 35176.73% in 2022.
  • Anaptysbio's Cash from Operations (Quarter) stood at -$25.3 million in 2021, then skyrocketed by 57.77% to -$10.7 million in 2022, then plummeted by 221.47% to -$34.3 million in 2023, then crashed by 94.1% to -$66.7 million in 2024, then soared by 58.97% to -$27.4 million in 2025.
  • Its Cash from Operations was -$27.4 million in Q3 2025, compared to -$40.2 million in Q2 2025 and -$10.7 million in Q1 2025.